BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 1, 2025
See today's BioWorld
Home
» Petra 'accelerates' into $48M series A to tackle cancer, metabolic disease
To read the full story,
subscribe
or
sign in
.
Petra 'accelerates' into $48M series A to tackle cancer, metabolic disease
Jan. 6, 2016
By
Marie Powers
No Comments
Petra Pharma Corp. became the first life science start-up for the 1-year-old New York arm of Accelerator Corp., initially established more than a dozen years ago in Seattle.
BioWorld